Medical Devices

A major partnership unites three top orthopedic providers, signaling a trend of consolidation and raising questions about patient care and physician autonomy.

The biopharma firm projects massive sales from its current drugs and bets big on a new Alzheimer's therapy, signaling a pivotal year of growth and innovation.

WNBA star Erica Wheeler lost her mom to cervical cancer. Now, she's teaming up with Hologic to tackle a worrying rise in cases and save lives.

A revolutionary bone graft that accelerates healing is now approved for more spinal surgeries, offering new hope to patients with chronic back pain.

For the third straight year, VIO Med Spa is the top franchise in its class. We explore the model driving its success in the booming wellness industry.

Kye Pharma brings SLENYTO®, a first-of-its-kind prescription sleep aid, to Canada, offering relief to children with ASD and SMS and their families.

A new partnership aims to solve radiology's biggest challenges by integrating a powerful AI engine directly into existing workflows, making it invisible yet indispensable.

MedTech firm Lifeward is acquiring Oramed's oral insulin tech, despite a past trial failure, in a high-stakes deal that could redefine both companies.

A new fellowship in Newfoundland and Labrador aims to solve critical gaps in anesthesiology, boosting the region's health innovation ecosystem.

Medical device firm CVRx is under investigation after its stock nosedived. Did management mislead investors about its salesforce stability?

The eyecare tech firm reports a strong fourth quarter fueled by its TearCare system, even as full-year results show a slight dip. Is this a turning point?

As regulations tighten, Americhem unveils new polymers designed to help medical device makers navigate PFAS bans and enhance device traceability.

Aptar's 'Beat the Blink' technology, in partnership with Bausch + Lomb, promises to solve the age-old problem of inaccurate eye drop dosing.

Pimicotinib, a once-daily pill for tenosynovial giant cell tumor, gains FDA review, offering new hope for patients beyond invasive surgery.

A new drill-free cavity treatment is regenerating teeth, attracting Wall Street, and aiming to solve a global health crisis. This is the story of Curodont™.

Private equity firm Five Arrows makes a majority investment in Blue Mountain to fuel AI innovation, product growth, and European expansion for its compliance software.

A new video shows Vitestro's Aletta® robot drawing blood. Can this AI-powered device solve staffing shortages and improve patient care worldwide?

LyfeSci's acquisition of Clinically Media aims to fix the clinical trial bottleneck by integrating patient recruitment, promising faster, more diverse studies.

As employers pull back coverage for pricey weight-loss drugs, a new partnership offers a flexible way to provide access without breaking the budget.

Austrian firm AOP Health secures nationwide access for its rapid heart rate drug, Rapiblyk™, by partnering with top US distributors. What does this mean for critical care?